Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IPF and PPF”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Not applicableLooking for participantsNCT07743996
What this trial is testing

Emotional and Social Experiences of Antifibrotic (AF) Therapy Among Idiopathic Pulmonary Fibrosis (IPF)/Progressive Pulmonary Fibrosis (PPF) Patients: A Real-World Study

Who this might be right for
Idiopathic Pulmonary FibrosisProgressive Pulmonary Fibrosis
Boehringer Ingelheim 100
Not applicableLooking for participantsNCT07269262
What this trial is testing

SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers

Who this might be right for
Progressive Pulmonary FibrosisInterstitial Lung Disease
Medical University of South Carolina 170
Testing effectiveness (Phase 2)Looking for participantsNCT07192939
What this trial is testing

Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Trial to Evaluate the Efficacy and Safety of HRS-9813 in Subjects With Pulmonary Fibrosis

Who this might be right for
IPF and PPF
Guangdong Hengrui Pharmaceutical Co., Ltd 270
Large-scale testing (Phase 3)Looking for participantsNCT05943535
What this trial is testing

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

Who this might be right for
Progressive Pulmonary FibrosisInterstitial Lung Disease
United Therapeutics 698
Not applicableNot Yet RecruitingNCT07673237
What this trial is testing

Remote Evaluation and Surveillance of Patients With Interstitial Lung Disease: Transforming ILD Care Delivery With Remote Monitoring

Who this might be right for
Fibrotic Interstitial Lung DiseaseIPF and PPFLung Fibrosis Interstitial
University of California, San Francisco 200
Large-scale testing (Phase 3)Active Not RecruitingNCT06238622
What this trial is testing

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

Who this might be right for
Idiopathic Pulmonary FibrosisProgressive Pulmonary Fibrosis
Boehringer Ingelheim 1,666
Large-scale testing (Phase 3)Not Yet RecruitingNCT07441408
What this trial is testing

Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
Bristol-Myers Squibb 2,380
Large-scale testing (Phase 3)Not Yet RecruitingNCT07805785
What this trial is testing

Assess the Efficacy and Safety of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Progressive Pulmonary Fibrosis (PPF)

Who this might be right for
Progressive Pulmonary FibrosisInterstitial Lung Disease
Insmed Incorporated 800
Not applicableLooking for participantsNCT07332117
What this trial is testing

A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Anti-fibrotic Medications

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)Progressive Pulmonary Fibrosis
Royal Brompton & Harefield NHS Foundation Trust 30
Not applicableNot Yet RecruitingNCT07722507
What this trial is testing

Antifibrotic Therapy Decision-Making in Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisIdiopathic Pulmonary FibrosisProgressive Pulmonary Fibrosis
Bristol-Myers Squibb 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06329401
What this trial is testing

A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisProgressive Pulmonary FibrosisPulmonary Fibrosis Secondary to Systemic Sclerosis+7 more
Avalyn Pharma Inc. 375
Not applicableLooking for participantsNCT06855329
What this trial is testing

PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

Who this might be right for
Progressive Pulmonary FibrosisInterstitial Lung Disease
University of Massachusetts, Worcester 500
Testing effectiveness (Phase 2)Looking for participantsNCT05139719
What this trial is testing

Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients

Who this might be right for
Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF)
Sunshine Lake Pharma Co., Ltd. 110